Meihua International Medical Technologies Co., Ltd. (MHUA) released a profit for full year that decreased from the same period last year The company's bottom line came in at $10.8 million, or $0.40 per share. This compares with $11.6 million, or $0.49 per share, last year. The company's revenue...
Shares of Meihua International Medical Technologies Co. Ltd. (MHUA) gained 8% on Wednesday morning after its NT-2000 surgical path analysis system facilitates world's second 5G remote robot-assisted lobectomy. MHUA is currently trading at $1.1200, up $0.0900 or 8.7260%, on the Nasdaq. The stock opened...
The following are some of the biotech stocks making strong moves in Wednesday's pre-market trading (as of 8.10 A.M. EDT).
August 13, 2026 05:33 ET The World Health Organization’s cancer research agency, the International Agency for Research on Cancer (IARC), has classified three widely used medicines as carcinogenic to humans.